Tenaya Therapeutics, Inc. (TNYA): Nasdaq/NYSE listing notice — Tenaya receives Nasdaq bid price deficiency notice; must regain compliance by Oct 13, 2025

Tenaya Therapeutics, Inc.

Closing bid price of TNYA common stock below $1.00 for 30 consecutive business days through April 12, 2025.
Nasdaq granted 180-day compliance period ending October 13, 2025; no immediate impact on listing.
To regain compliance, shares must close at $1.00 or higher for at least 10 consecutive business days.
If not cured, Company may seek a second 180-day period by transferring to Nasdaq Capital Market.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Tenaya Therapeutics, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5450(a)(1), 5810(c)(3)(A)

Exact text from the filing

April 15, 2025, Tenaya Therapeutics, Inc. (the “Company”) received a letter from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, based upon the closing bid price of shares of the Company’s common stock for the 30 consecutive business day period between March 3, 2025, through April 12, 2025, the Company did not meet the minimum bid price of $1.00 per share required for continued listing on the Nasdaq Global Select Market pursuant to Nasdaq Listing Rule 5450(a)(1). The letter also indicated that the Company will be provided with a complia

View on SEC.gov

Browse all listing & compliance notices →

Tenaya Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-25-055927

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.